https://it.marketscreener.com/quotazioni/azione/KODIAK-SCIENCES-INC-46434640/attualita/Kodiak-Sciences-riporta-i-risultati-positivi-dello-studio-di-fase-3-Beacon-di-Tarcocimab-Tedromer-K-41249458/?utm_source=telegram&utm_medium=social&utm_campaign=share